Zenrelia™: Simple, consistent once-daily dosing from the start1
Zenrelia works fast. Over the first 14 days of treatment, once-daily dosing with Zenrelia achieves comparable reductions in itch scores to twice-daily dosing with Apoquel®.2**
Dosing made simple
Once a daySimple, consistent once daily dosing from the start, with no treatment breaks for vaccination required1†
HypoallergenicZenrelia tablets are free from flavour additives that could trigger food allergies1
Easy to administerZenrelia is given once daily from the start, with or without food1
Rapid reliefWith Zenrelia, owners can see visible itch relief after just one dose2
Owner complianceOwners are more likely to adhere to once-daily treatment vs twice daily2-4
Dosing Zenrelia
Zenrelia is supplied in 4 strengths and is dosed once-daily at 0.6-0.8 mg/kg body weight.1
How to open the Zenrelia blister pack
Sizes of Zenrelia tablets
The tablet illustrations are for visual reference only and not actual size.
Veterinary experts rate Zenrelia
“Zenrelia will benefit the owners of dogs with atopic dermatitis because they're going to be much less itchy. They're also only going to need to give medication once a day and that makes it simple to prescribe. I would absolutely prescribe Zenrelia myself and if my dog was itchy I would use it on my dog.”
Dr Helena Langley BVetMed, CertVD, MRCVS
GP Vet (Dermatology Focus)
Safety profile
Zenrelia has a safety profile comparable to Apoquel®. 2 It can be used long term, alongside commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.1,2 †
Zenrelia is well tolerated when used long term for maintenance therapy. 5 ¶
Zenrelia may be use alongside vaccination, with no treatment breaks required1 ‡
Questions?
Zenrelia Resources
* Referenceable claims in digital & social copy can be found on this page. Full reference list below.
** Based on PVAS scores over first 14 days of treatment2
† Please refer to SPC section 3.8 for more information1
‡ The decision should be made according to a benefit:risk assessment by the responsible veterinary surgeon. Please refer to SPC section 3.8 for more information1
¶Based on Zenrelia use over a six-month period1
- Zenrelia Summary of Product Characteristics
- Forster S et al. Vet Dermatol 2025 Apr,36(2):165-176.
- Spitznagel MB et al. Vet Dermatol. 2021 Apr;32:192–e50
- Boda C et al. Intern J Appl Res Vet Med. 2011;9:157–65
- Kuntz EA et al. BMC Vet Res. 2025 Mar; 21:144.
